低pH条件下单克隆抗体凝胶化过程的微流变学研究。

IF 4.5 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Conor M. Lewis, Thomas A. Waigh*, Anna M. Stephens, Jian R. Lu, Charles T. Heise, Natalia Harasimiuk and Jennifer Tovey, 
{"title":"低pH条件下单克隆抗体凝胶化过程的微流变学研究。","authors":"Conor M. Lewis,&nbsp;Thomas A. Waigh*,&nbsp;Anna M. Stephens,&nbsp;Jian R. Lu,&nbsp;Charles T. Heise,&nbsp;Natalia Harasimiuk and Jennifer Tovey,&nbsp;","doi":"10.1021/acs.molpharmaceut.5c00220","DOIUrl":null,"url":null,"abstract":"<p >Non-native aggregation of monoclonal antibodies (mAbs) during downstream processing can reduce their efficacy (e.g., in immunotherapies) and the total yield. The pH of mAb solutions was lowered, similar to steps during viral inactivation and protein A chromatography, and a continuous phase transition to a physically cross-linked gel was observed via microrheology. The dynamic power-law scaling of the shear modulus on the frequency, <i>G′</i>(ω) ∝ <i>G</i>″(ω) ∝ ω<sup><i>n</i></sup>, was calculated using time-cure superposition, yielding a dynamical critical exponent, <i>n</i> = 0.52 ± 0.05. Dynamic light scattering showed a similar power law scaling exponent of μ = 0.49 ± 0.04 about the gel point which is related to the fractal dimension. Circular dichroism showed large increases in the β-sheet content of the mAbs at low pHs combined with a large increase in fluorescence of a ThT stained sample. Thus, mAb gelation seems to occur via the formation of amyloid fibrils that cause a continuous phase transition that is well described by a dynamic scaling model for percolation.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":"22 8","pages":"4624–4631"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Microrheology of Monoclonal Antibodies during Gelation under Low pH Conditions\",\"authors\":\"Conor M. Lewis,&nbsp;Thomas A. Waigh*,&nbsp;Anna M. Stephens,&nbsp;Jian R. Lu,&nbsp;Charles T. Heise,&nbsp;Natalia Harasimiuk and Jennifer Tovey,&nbsp;\",\"doi\":\"10.1021/acs.molpharmaceut.5c00220\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Non-native aggregation of monoclonal antibodies (mAbs) during downstream processing can reduce their efficacy (e.g., in immunotherapies) and the total yield. The pH of mAb solutions was lowered, similar to steps during viral inactivation and protein A chromatography, and a continuous phase transition to a physically cross-linked gel was observed via microrheology. The dynamic power-law scaling of the shear modulus on the frequency, <i>G′</i>(ω) ∝ <i>G</i>″(ω) ∝ ω<sup><i>n</i></sup>, was calculated using time-cure superposition, yielding a dynamical critical exponent, <i>n</i> = 0.52 ± 0.05. Dynamic light scattering showed a similar power law scaling exponent of μ = 0.49 ± 0.04 about the gel point which is related to the fractal dimension. Circular dichroism showed large increases in the β-sheet content of the mAbs at low pHs combined with a large increase in fluorescence of a ThT stained sample. Thus, mAb gelation seems to occur via the formation of amyloid fibrils that cause a continuous phase transition that is well described by a dynamic scaling model for percolation.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\"22 8\",\"pages\":\"4624–4631\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00220\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00220","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

在下游加工过程中,单克隆抗体(mab)的非天然聚集会降低其功效(例如,在免疫治疗中)和总产量。降低单抗溶液的pH值,类似于病毒灭活和蛋白A层析的步骤,通过微流变学观察到连续的相变到物理交联凝胶。采用时间固化叠加法计算剪切模量随频率的动态幂律标度,即G′(ω)∝G″(ω)∝ωn,得到动态临界指数n = 0.52±0.05。动态光散射在凝胶点处表现出近似的幂律标度指数μ = 0.49±0.04,与分形维数有关。圆形二色性表明,在低ph值下,单抗的β-片含量大幅增加,ThT染色样品的荧光也大幅增加。因此,单抗凝胶化似乎是通过淀粉样蛋白原纤维的形成而发生的,淀粉样蛋白原纤维的形成导致了一个连续的相变,这个相变可以用渗流的动态缩放模型很好地描述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Microrheology of Monoclonal Antibodies during Gelation under Low pH Conditions

Microrheology of Monoclonal Antibodies during Gelation under Low pH Conditions

Non-native aggregation of monoclonal antibodies (mAbs) during downstream processing can reduce their efficacy (e.g., in immunotherapies) and the total yield. The pH of mAb solutions was lowered, similar to steps during viral inactivation and protein A chromatography, and a continuous phase transition to a physically cross-linked gel was observed via microrheology. The dynamic power-law scaling of the shear modulus on the frequency, G′(ω) ∝ G″(ω) ∝ ωn, was calculated using time-cure superposition, yielding a dynamical critical exponent, n = 0.52 ± 0.05. Dynamic light scattering showed a similar power law scaling exponent of μ = 0.49 ± 0.04 about the gel point which is related to the fractal dimension. Circular dichroism showed large increases in the β-sheet content of the mAbs at low pHs combined with a large increase in fluorescence of a ThT stained sample. Thus, mAb gelation seems to occur via the formation of amyloid fibrils that cause a continuous phase transition that is well described by a dynamic scaling model for percolation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信